Investigación en Enfermidades Hematolóxicas
Hospital Severo Ochoa
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Severo Ochoa (9)
2021
-
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura
Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573
2020
-
Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort
Thrombosis and Haemostasis, Vol. 120, Núm. 3, pp. 437-448
2019
-
Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients
Blood Coagulation and Fibrinolysis, Vol. 30, Núm. 3, pp. 127-132
-
Unraveling the effect of silent, intronic and missense mutations on VWF splicing: Contribution of next generation sequencing in the study of mRNA
Haematologica, Vol. 104, Núm. 3, pp. 587-598
2018
2017
-
Molecular and clinical profile of von willebrand disease in Spain (PCM-EVW-ES): Comprehensive genetic analysis by next-generation sequencing of 480 patients
Haematologica, Vol. 102, Núm. 12, pp. 2005-2014
2016
-
Molecular and clinical profile of von willebrand disease in spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm
Thrombosis and Haemostasis, Vol. 115, Núm. 1, pp. 40-50
2011
-
Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab
Expert Review of Hematology, Vol. 4, Núm. 1, pp. 9-16
2008
-
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: The influence of prior exposure to rituximab on outcome. A GEL/TAMO study
Haematologica, Vol. 93, Núm. 12, pp. 1829-1836